RSS icon

Top Stories

Top Stories - Frontpage

Specialty Drugs and the Cost Conundrum

January 3, 2013
Steep prices of specialty drugs—such as Humira or Enbrel, which can cost more than $14,000 annually—are prompting employers to focus on managing the expense. But the question is how. “There are lots of cogs in this wheel and that complicates the management of these drugs,” says Cheryl Larson, vice president of the Midwest Business Group on Health.
Read More

DuPont Sees Bottom-Line Boost After Retooling Its Rewards

December 17, 2012
Early results of DuPont's program have been encouraging, giving company leaders hope that its new recognition system will have a measurable effect on the company's overall business objectives. Studies also show that companies excelling in employee recognition are 12 times more likely to generate strong business results than their peers.
Read More